Food allergy treatments, including antihistamines, epinephrine, immunotherapy, and biologics like Xolair, address a condition affecting 250 million people globally, with 32 million in the U.S. (5.6 million children). The market is driven by rising prevalence (peanut allergy doubled in 20 years), advanced diagnostics (20% fewer misdiagnoses), and therapies like oral immunotherapy (OIT), increasing tolerance by 60%. Strict allergen labeling and 65% OECD reimbursement coverage boost access. The global food allergy treatment market is estimated at USD 4.0-7.0 billion in 2025, with a CAGR of 5.0%-10.0% through 2030.
This product will be delivered within 1-3 business days.
Regional Market Trends
- North America: The U.S. leads with high peanut allergy rates and Xolair adoption, while Canada emphasizes allergen labeling.
- Europe: Germany, France, and the UK drive growth with robust allergy programs.
- Asia Pacific: Australia expands immunotherapy, while China focuses on diagnostic access.
- Rest of the World: Brazil improves allergy care, while the Middle East addresses pediatric allergies.
Distribution Channel Analysis
- Hospital Pharmacies: Expected growth of 5.5%-10.5%, driven by epinephrine and biologics. Trends focus on emergency care.
- Retail Pharmacies: Projected growth of 5.0%-10.0%, linked to antihistamines. Advances emphasize accessibility.
- Others: Anticipated growth of 4.5%-9.5%, covering online platforms. Trends highlight digital access.
Type Analysis
- Antihistamines: Expected growth of 4.5%-9.5%, for mild reactions. Trends focus on OTC formulations.
- Epinephrine: Projected growth of 5.0%-10.0%, for anaphylaxis. Advances emphasize auto-injector designs.
- Immunotherapy: Anticipated growth of 6.0%-11.0%, for long-term tolerance. Trends highlight OIT and EPIT.
- Xolair: Expected growth of 6.5%-11.5%, for severe cases. Developments prioritize expanded indications.
- PALFORZIA: Expected growth of 6.2%-11.2%, for peanut allergy. Trends focus on pediatric use.
- Others: Expected growth of 4.8%-9.8%, covering novel therapies. Developments prioritize biologics.
Key Market Players
- Stallergenes Greer: Offers immunotherapy solutions.
- DBV Technologies: Develops Viaskin Peanut.
- Roche: Provides Xolair for allergies.
- Sanofi: Supplies epinephrine auto-injectors.
- Aravax: Innovates peanut allergy therapies.
Porter’s Five Forces Analysis
- Threat of New Entrants: Moderate, due to high R&D costs, but unmet needs lower barriers.
- Threat of Substitutes: Moderate, with avoidance strategies competing, but therapies are primary for severe cases.
- Bargaining Power of Buyers: Moderate, with insurers negotiating prices, but urgent needs limit leverage.
- Bargaining Power of Suppliers: Low, with multiple API providers.
- Competitive Rivalry: High, with players competing on efficacy and delivery.
Market Opportunities and Challenges
Opportunities:
- Addressing 250 million food allergy patients.
- Leveraging peanut allergy, affecting 30% of U.S. children cases.
- Utilizing advanced diagnostics, reducing misdiagnoses by 20%.
- Supporting OIT, improving tolerance by 60%.
- Benefiting from 65% OECD reimbursement coverage.
- Expanding strict allergen labeling globally.
Challenges:
- High costs of biologics and immunotherapy.
- Regulatory delays for novel therapies.
- Limited access in low-income regions.
- Patient adherence issues with OIT regimens.
- Risk of adverse reactions requiring monitoring.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Food Allergy Treatment Market in North America (2020-2030)
Chapter 9 Historical and Forecast Food Allergy Treatment Market in South America (2020-2030)
Chapter 10 Historical and Forecast Food Allergy Treatment Market in Asia & Pacific (2020-2030)
Chapter 11 Historical and Forecast Food Allergy Treatment Market in Europe (2020-2030)
Chapter 12 Historical and Forecast Food Allergy Treatment Market in MEA (2020-2030)
Chapter 13 Summary For Global Food Allergy Treatment Market (2020-2025)
Chapter 14 Global Food Allergy Treatment Market Forecast (2025-2030)
Chapter 15 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- Stallergenes Greer
- DBV Technologies
- Roche
- Sanofi
- Aravax
- Novartis
- Alladapt Immunotherapeutics
- Teva Pharmaceuticals
- Vedanta Biosciences
- COUR Pharmaceuticals
- Prota Therapeutics